FDA DTC Stance Is “Ideological,” Not Science-Based, Rep. Waxman Says
Executive Summary
FDA's "slanted" interpretation of its DTC physician survey results shows the agency is straying from its science-based mission, Rep. Henry Waxman maintains
You may also be interested in...
DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting
Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs
DTC Comparative Drug Campaigns To Be Addressed At FDA Public Meeting
Standards for comparative drug claims in direct-to-consumer ads will be one topic for discussion during a Sept. 22-23 FDA public meeting on consumer-directed promotion of prescription drugs
DTC Guidance Is High Priority In First Amendment Review, FDA Says
Direct-to-consumer ads are likely to be addressed by FDA early in the upcoming series of First Amendment guidances, Associate Deputy Chief Counsel Seth Ray said during the Food & Drug Law Institute Annual Education Conference in Washington, D.C. April 2